Digital supply chain solutions for visibility, quality, and compliance.
Optional and bespoke services to help you get started and scale.
To further in the mission of unleashing zero-waste supply chains and support further growth, Controlant expands its operations for its customers in the pharmaceutical, food, and transportation industries and is opening a new office in the historic center of Wroclaw, Polland.
The new Controlant Wroclaw office was formally opened today September 1st by Gísli Herjólfsson, CEO and Controlant, and Jakub Mazur, Deputy Mayor of Wroclaw. The office currently employs over 20 talented and highly skilled individuals in customer support, Logistics, Finance and Human resources. The aim is to expand the Controlant team in Poland further and recruit top talent for all divisions with a special focus on research and development.
Controlant was founded in Iceland in 2007 and now employs over 370 people from over 50 nationalities. In addition to its headquarters in Iceland and the new office in Poland, Controlant also operates service centers in the U.S. and the Netherlands. Controlant offers its employees a first-class working environment with a vibrant culture based on diversity, respect, and a lifelong learning mentality.
“We are a fast-growing company with ambitious goals and strategy for the future, and we need to be equipped and ready for the journey ahead of us. From our new office in Wroclaw, we are in a strong position to strengthen our existing customer relationships and create new ones. We also access a massive pool of experienced top talent from major European academic institutions. We feel welcome in Wroclaw and look forward to growing our team there.”
“The decision taken by Controlant is a valuable step for both the city and the company itself. Opening an office in Wroclaw will allow the company to recruit talent from the academic community while having close access to European clients. The city will gain quality jobs. Controlant is a strong brand that has played an important role in the safe distribution and monitoring of COVID-19 vaccines around the world. We look forward to its further development”.